Methyltestosterone

DB06710ApprovedInvestigationalSmall moleculeAndrogens

Methyltestosterone is a synthetic anabolic steroid used for the replacement therapy in conditions associated with testosterone deficiencies in males, such as hypogonadism, and treatment of advancing inoperable metastatic breast cancer in females. Also, has antineoplastic properties and so has been used secondarily in women with advanced breast cancer.

Chemical structure of Methyltestosterone
Mechanism
Curator reviewed
Primary indication
Methyltestosterone is an anabolic steroid hormone used to treat men with a testosterone deficiency.Curator reviewed · 5 structured indications
Formula / weight
C20H30O2 · 302.451 g/mol (avg)
First approval
Canada, 1997 · United States, 1973
Also known as
17-methyltestosterone · Virilon
Code names
L 589.372 · NSC-139965 · RU 24400
Brand names
  • Covaryx
  • Methitest

Resolves to

Structure
InChIKeyGCKMFJBGXUYNAG-HLXURNFRSA-NSMILES[H][C@@]12CC[C@](C)(O)[C@@]1(C)CC[C@@]1([H])[C@@]2([H])CCC2=CC(=O)CC[C@]12C

What you can answer from here — as of September 23, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
1,406Drug interactionsStructured to mechanism, not free text
Sign in
7Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Structured indicationsCondition, population, route and combination as fields, not prose
Sign in
4ContraindicationsEach with its own population and attribute set
Sign in
71Marketed productsAcross 4 countries and 23 labellers
Sign in
3ATC codesIncluding every combination product, plus 25 drug categories
Sign in
17+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Methyltestosterone, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.

Create Account